Castle Biosciences Inc.

20.25
0.47 (2.38%)
At close: Apr 02, 2025, 3:59 PM
20.10
-0.74%
Pre-market: Apr 03, 2025, 07:20 AM EDT

Castle Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Revenue 332.07M 219.79M 137.04M 94.08M 62.65M 51.87M 22.79M 13.75M
Cost of Revenue n/a 44.98M 32.01M 15.82M 9.69M 7.31M 5.3M 4.92M
Gross Profit 332.07M 174.81M 105.03M 78.26M 52.96M 44.55M 17.49M 8.83M
Operating Income 8.67M -67.98M -91.14M -40.08M -6.54M 4.71M -3.84M -10.9M
Interest Income 12.92M 10.62M 3.97M 68K 373K 312K 23.51K 26.18K
Pretax Income 21.56M -57.37M -68.9M -40.01M -10.2M 5.35M -6.36M -12.36M
Net Income 18.25M -57.47M -67.14M -31.29M -10.28M 5.28M -6.37M -12.37M
Selling & General & Admin 200.05M 180.15M 143M 86.74M 48.13M 29.84M 16.47M 15.26M
Research & Development 52.04M 53.62M 44.9M 29.65M 13.26M 7.38M 4.85M 4.47M
Other Expenses 71.31M 9.01M 8.27M 1.96M -1.88M -2.93M -272.42K 163.29K
Operating Expenses 323.4M 242.78M 196.17M 118.34M 59.51M 37.23M 21.32M 19.73M
Interest Expense 577K 11K 17K 1K 2.63M 4.57M 2.27M 1.65M
Selling & Marketing Expenses 123.47M 113.66M 86.61M n/a n/a n/a n/a n/a
Cost & Expenses 323.4M 287.76M 228.18M 134.16M 69.19M 44.54M 26.62M 24.65M
Income Tax 3.32M 101K -1.77M -8.72M 84K 72K 8.61K 9.73K
Shares Outstanding (Basic) 27.78M 26.8M 26.05M 25.14M 18.93M 8.58M 10.65M 9.78M
Shares Outstanding (Diluted) 29.25M 26.8M 26.05M 25.14M 18.93M 8.66M 10.65M 9.78M
EPS (Basic) 0.66 -2.14 -2.58 -1.24 -0.54 0.35 -0.6 -1.26
EPS (Diluted) 0.62 -2.14 -2.58 -1.24 -0.54 -0.21 -0.6 -1.26
EBITDA 38.14M -45.02M -58.34M -36.6M -7.09M 7.69M -3.76M -10.4M
EBIT 22.14M -57.35M -68.89M -40.01M -7.57M 7.33M -4.08M -10.71M
Depreciation & Amortization 16M 12.33M 10.54M 3.41M 472K 358K 323.02K 310.82K